Table 2.
Key input parameters to computer simulation
| Parameter description | Point estimate | Range | Source | |||
|---|---|---|---|---|---|---|
| PrEP characteristics | ||||||
| Relative risk reduction on sexual transmission of HIV associated with PrEP use | 44% | 25–75% | [1–3] | |||
| Relative risk reduction on parenteral transmission of HIV associated with PrEP use | 49% | 25–75% | [5] | |||
| Uptake of PrEP in prioritized population | 50% | 10–90% | [22, 24, 26, 39–41] | |||
| Cost of PrEP per person per year | $9,672 | $4,836–19,345 | [11, 14, 16] | |||
| Population characteristics | ||||||
| Proportion of population who are abstinent | 21% | 15–25% | [42] | |||
| Proportion of men who are MSM (exclusively or non-exclusively) | 6% | 4–10% | [28] | |||
| Probability of monogamous relationship (if sexually active) | ||||||
| Men who have sex with men (MSM) | 56% | 44%–75% | [28] | |||
| Men who have sex with women (MSW) | 78% | 76%–84% | [28] | |||
| Probability of multiple partnerships (if sexually active) | ||||||
| MSM | 44% | 25%–64% | [28] | |||
| MSW | 22% | 16%–24% | [28] | |||
| WSM | 9% | 7–10% | [28] | |||
| Proportion of population that are injection drug users (IDU) | 1.4% | 1.0–1.9% | [43] | |||
| Proportion of IDU that have unsafe injection practices | 32% | 23%–50% | [44] | |||
| Shared injections per year (if unsafe IDU) | 70 | 25–100 | Expert opinion | |||
| Sex acts (per partnership) per year | 89 | 50–100 | [45] | |||
| HIV related characteristics | ||||||
| Probability of annual HIV test | 31% | 10%–50% | [28] | |||
| Probability of adherence to ART | 63% | 50–75% | [46] | |||